Diabetic Macular Edema (DME) Active Not Recruiting Phase 3 Trials for Aflibercept (DB08885)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03622580A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)Treatment
NCT02634333Anti-VEGF Treatment for Prevention of PDR/DMEPrevention